Prof. Hugh O’Brodovich
M.D., Chair, Dept. of Pediatrics, Stanford University School of Medicine; Adalyn Jay Physician in Chief at Lucile Packard Children’s Hospital
Prof. O’Brodovich has been the Associate Editor of the American Review of Respiratory Disease, Editor of Pediatric Research, and a member of the editorial board of the American Journal of Physiology and served as a member of the CHRI’s Advisory Board of the Institute of Human Development Child and Youth Health. He has published 164 peer reviewed manuscripts and 21 book chapters and holds two patents.
In 2010, Prof. O’Brodovich was appointed the inaugural director of the Child Health Research Institute at Stanford.
Andrew R. Colin
M.D., Director, Division of Pediatric Pulmonology, University of Miami Leonard M. Miller School of Medicine
Prof. Andrew Colin has served as clinical director of the Division of Respiratory Diseases and was associate professor at Harvard Medical School. He also was the associate director of the Cystic Fibrosis Center, and Director of the Pulmonary Function Lab, including development and directorship of the only infant pulmonary function lab in New England.
Prof. Colin has participated in over 20 studies, including some sponsored by the NIH, Genentech, GlaxoSmithKline, and the Therapeutic Development Network of the Cystic Fibrosis Foundation. He has authored or co-authored over 80 peer-reviewed publications, as well as multiple reviews and book chapters.
John P. Clancy
M.D., Research Director, Division of Pulmonary Medicine, Cincinnati Children’s Hospital; Professor, University of Cincinnati Dept. of Pediatrics
Dr. John Clancy has served in several leadership roles at the University of Alabama, Cincinnati Children’s Hospital, and in the international CF community. His leadership roles include membership on several committees associated with the Cystic Fibrosis Foundation, such as DSMB membership for the Rare Lung Disease Consortium in the NIH Rare Disease Research Network, of which is now chairman.
Dr. Clancy was the initial recipient of two endowed chairs, the Raymond K. Lyrene Chair in Pediatric Pulmonary Medicine at the University of Alabama (2005) and the Tom Boat Chair in Cystic Fibrosis Clinical and Translational Research at Cincinnati Children’s (2011).
Jerome B. Zeldis
M.D., Ph.D., CEO, Celgene Global Health; CMO, Celgene Corporation
Since 1997, Dr. Jerome Zeldis has been the CEO of Celgene Global Health and CMO of Celgene Corporation. Previously, he served as Celgene’s senior VP of Clinical Research and Medical Affairs. He serves on the board of directors of Soligenix, Inc. and Alliqua, Inc.
Dr. Zeldis was an assistant professor of medicine at Harvard Medical School, associate professor of medicine at University of California, Davis, and clinical associate professor of medicine at Cornell Medical School. He was a professor of clinical medicine at the Robert Wood Johnson Medical School at Rutgers University.
M.D., Kenneth Macintosh Chair in Pediatric Infectious Diseases and Senior Physician in Medicine, Division of Infectious Diseases, Boston Children’s Hospital and Professor of Pediatrics, Harvard Medical School.
Dr. Richard Malley is a Senior Physician in Medicine and an attending in the division of pediatric infectious diseases at Boston Children’s Hospital. He is a Professor of Pediatrics at Harvard Medical School.
His research interests include Pneumococcal pathogenesis and immunity as well as vaccine development. He has authored more than 85 scientific articles. Dr. Malley is board certified in Pediatrics, Pediatric Emergency Medicine and Pediatric Infectious Diseases by the American Board of Pediatrics. Dr. Malley received his M.D. from Tufts University School of Medicine and has been in practice for over 25 years. He completed an internship, residency and fellowship at Boston Children’s Hospital
Prof. Asher Tal
M.D., Professor, Pediatrics; Head, Dept. of Pediatrics, Soroka Medical Center
Prof. Asher Tal founded and has previously been the head of the Pediatric Pulmonary Unit at Soroka Medical Center. During the past 15 years, he has also been the physician in charge of Soroka’s Pediatric Sleep Center. Soroka is affiliated with the Faculty of Health Sciences of Ben-Gurion University of the Negev.
Prof. Tal’s research interests include childhood asthma, bronchiolitis and wheezing in infancy, sleep-disordered breathing, pediatric and adult obstructive sleep apnea syndrome, and insomnia.
Prof. Tal has authored or co-authored more than 100 publications and is a member of the editorial board of Pediatric Pulmonology. Since 2008, Dr. Tal has chaired the Israeli Association of Pediatric Pulmonology.
Prof. Hannah Blau
M.D., Director, Pulmonology Clinic at the Kathy and Lee Graub Cystic Fibrosis Center, Schneider Children’s Medical Center of Israel in Petah Tikva
Prof. Hannah Blau is a founding member (now secretary) of the Israeli Society for Cystic Fibrosis and was a founding member of the Israel Society for Pediatric Pulmonology.
She is a member of the International Pediatric Pulmonary Network of the American Thoracic Society, has served on the Program Committee for the ATS conference, and is a member of the Pediatric Infection and Immunology Committee of the European Respiratory Society Pediatric Assembly. She is a member of the Newborn Screening Working Group of the European Cystic Fibrosis Society and now leads the preparation of standards of practice for sputum induction as part of the ECFS.
Her fields of research include CF, asthma, lung cell biology and inflammation. In particular, recent work has focused on induced sputum in the very young for early markers of inflammation and infection; emerging infections in CF, spectrum of CF phenotypes, preschool pulmonary function testing.
Prof. Blau is a reviewer for eight international medical journals and is an author or co-author of 85 peer-reviewed manuscripts.
Prof. Gidi Paret
M.D., Director, Dept. of Pediatric Intensive Care, Sheba Medical Center
Prof. Gidi Paret is the director of the Laboratory of Molecular Biology of the Department of Critical Care at Sheba Medical Center.
His research interests are in both clinical and bench research, including inflammatory response to surgery in children innovative drugs for CPR and the effect of genetic material on the post-operative course.
Prof. Paret has authored more than 150 scientific peer review publications, review articles, and book chapters. He is a member of the editorial boards of Pediatric Critical Care Medicine, the Journal of Pediatric Intensive Care, and F1000.
Prof. Paret is director of the MD graduate program of Tel-Aviv University’s Sackler School of Medicine. He served as head of the Israeli Society of Pediatric Critical Care, and is a member of the world federation of Pediatric Intensive Care and of the National Council of Health.